Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Numerous studies published recently on soon-to-be-introduced ARB olmesartan

June 22, 2001

PROGRESS trials show Aceon/diuretic combination reduces recurrent stroke by 50%

June 22, 2001

Grupo Vita uses Spain as reference member state for approval of enalapril/nitrendipine

June 21, 2001

Role of calcineurin in cardiac hypertrophy and subsequent heart failure

June 20, 2001

Adipocyte-specific protein and essential hypertension

June 20, 2001

Solvay commences Canadian study of Teveten in combination with home blood pressure monitoring

June 19, 2001

Cardioprotective properties demonstrated for LU-135252 in infarcted SHSRP

June 19, 2001

Worldwide clinical development program for Generx to be launched

June 19, 2001

Potent inhibitors of cGMP-PDE and potential uses reported in international patent

June 18, 2001

Boehringer Ingelheim announces TRANSCEND trial in ACE-intolerant patients

June 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...